Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2003
07/03/2003WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003WO2003053922A2 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003WO2003053466A1 Skin barrier function repair accelerators
07/03/2003WO2003053446A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors
07/03/2003WO2003053442A1 Tempamine compositions and methods of use
07/03/2003WO2003053441A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
07/03/2003WO2003053430A1 Drinkable preparation comprising ketoprofen and the use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain
07/03/2003WO2003053407A1 Liposomal delivery of vitamin e based compounds
07/03/2003WO2003053374A1 Use of an extract of the baptisia tinctoria plant in a cosmetic composition
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
07/03/2003WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
07/03/2003WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function
07/03/2003WO2003053336A2 Methods for the treatment of peripheral neural and vascular ailments
07/03/2003WO2003053331A2 Protease inhibitors
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2003053158A2 Malleable protein matrix and uses thereof
07/03/2003WO2003030823A3 Combinations for the treatment of immunoinflammatory disorders
07/03/2003WO2003026697A3 Organoleptically acceptable intraorally disintegrating compositions
07/03/2003WO2002084249A3 Therapeutic and diagnostic uses of antibody specificity profiles
07/03/2003WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor
07/03/2003WO2002050279A3 Nucleic acid-associated proteins
07/03/2003WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/03/2003WO2002022801A9 Mammalian receptor genes and uses
07/03/2003WO2001098365A3 Peptide and polypeptide inhibitors of complement c1s
07/03/2003US20030125800 Drug-delivery endovascular stent and method for treating restenosis
07/03/2003US20030125572 Useful as a cosmetic constituent, antioxidant, radical scavenger or anti-inflammatory agent
07/03/2003US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder
07/03/2003US20030125559 Methods for synthesizing ether compounds and intermediates therefor
07/03/2003US20030125557 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
07/03/2003US20030125509 Indomethacin entrapped within polysaccaride (dextran) or proteins
07/03/2003US20030125380 Tricyclic rantes receptor ligands
07/03/2003US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor
07/03/2003US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis
07/03/2003US20030125360 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
07/03/2003US20030125356 Reacting a methylketophenolic compound with a benzaldehyde compound to produce an intermediate, cyclizing the intermediate in presence of a base; anticarcinogenic agent, and treats diseases induced by cell proliferation
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125350 Combination of formoterol and a tiotropium salt
07/03/2003US20030125339 Substituted alkylamine derivatives and methods of use
07/03/2003US20030125332 Pyrazolo(3,4-c)pyridazin-3-ylamine derivatives; glycogen synthase kinase-3 (gsk-3); treatment and prevention of diabetes and Alzheimer's disease
07/03/2003US20030125330 Anxiolytics and antidepressants
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003US20030125299 Method for treating or preventing inflammatory diseases
07/03/2003US20030125294 Selective toxin expression in angiogenic endothelial cells
07/03/2003US20030125286 Transcriptional silencer protein NRF
07/03/2003US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment
07/03/2003US20030124677 Amino-terminally truncated MCP-2 as chemokine antagonists
07/03/2003US20030124649 Membrane associated proteins
07/03/2003US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents
07/03/2003US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2)
07/03/2003US20030124196 Pulsatile release compositions and methods for enhanced intestinal drug absorption
07/03/2003US20030124193 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale.
07/03/2003US20030124190 Methods and compositions for treating pain of the mucous membrane
07/03/2003US20030124174 Method for treating non-neuropathic pain
07/03/2003US20030124159 Enhancing epidermal barrier development in skin
07/03/2003US20030124150 Kit for reducing aching
07/03/2003US20030124129 Angiopoietin-2 specific binding agents
07/03/2003US20030124110 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases
07/03/2003US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof
07/03/2003CA2486930A1 Anti-tirc7 antibodies in therapy of inflammatory diseases
07/03/2003CA2486689A1 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
07/03/2003CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003CA2471136A1 Mono-and dual chemokine/cytokine constructs
07/03/2003CA2471085A1 Aroyl pyridinones
07/03/2003CA2471083A1 Benzhydryl derivatives
07/03/2003CA2471079A1 Piperidine-2,6-diones heterocyclically substituted in the 3-position
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2470813A1 1,4-dihydro-1,4-diphenylpyridine derivatives
07/03/2003CA2470776A1 Malleable protein matrix and uses thereof
07/03/2003CA2470612A1 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
07/03/2003CA2470603A1 Methods for the treatment of peripheral neural and vascular ailments
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003CA2470364A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
07/03/2003CA2469263A1 Raf/ras binding compounds
07/03/2003CA2469047A1 Tempamine compositions and methods of use
07/03/2003CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/03/2003CA2436850A1 Protease inhibitors
07/02/2003EP1323738A1 Negatively charged polysaccharide derivable form Aloe Vera
07/02/2003EP1323713A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1323709A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
07/02/2003EP1323424A1 Buffalo milk gangliosides
07/02/2003EP1322769A2 Protein phosphatases
07/02/2003EP1322760A2 G-protein coupled receptors
07/02/2003EP1322755A1 Human and mouse targeting peptides identified by phage display
07/02/2003EP1322752A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
07/02/2003EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
07/02/2003EP1322629A1 Tetrahydrofuran derivatives and their use as nk-1 antagonists
07/02/2003EP1322627A1 Cyclic sulfonyl compounds as inhibitors of metalloproteases
07/02/2003EP1322618A1 Amino heterocyclic compounds (factor x a? inhibitors 14)
07/02/2003EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322611A1 Chemical compounds
07/02/2003EP1322596A1 Zwitterionic tachykinin receptor antagonists
07/02/2003EP1322593A1 O-substituted 6-methyl-tramadol derivatives
1 ... 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 ... 1272